ResMed Announces Participation in the Goldman Sachs 42nd Annual Global Healthcare Conference
ResMed (NYSE: RMD) announced that Rob Douglas, president and COO, will participate in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8, 2021, at 1:20 p.m. EDT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ResMed (NYSE: RMD) announced that Rob Douglas, president and COO, will participate in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8, 2021, at 1:20 p.m. EDT. The chat will be available via a live video webcast, with a replay accessible approximately 12 hours after the event, remaining available until June 8, 2022. ResMed focuses on innovative health solutions for chronic diseases, aiming to improve quality of life and lower healthcare costs globally.
Positive
- Participation in reputable Goldman Sachs healthcare conference highlights the company's visibility in the healthcare sector.
- Focus on digital health technologies could position ResMed for growth in a rapidly evolving healthcare landscape.
Negative
- None.
Details
News Market Reaction – RMD
The recorded move for RMD in the trading session of this news was -1.30%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, June 02, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021, beginning at approximately 1:20 p.m. (Eastern Daylight Time) via video webcast.
More information about this event, including access to the live webcast, may be accessed by visiting http://investor.resmed.com. The webcast replay will be available approximately 12 hours after the live webcast ends and will be accessible through June 8, 2022.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors | For media |
| Amy Wakeham | Jayme Rubenstein |
| +1 858.836.5000 | +1 858.836.6798 |
| investorrelations@resmed.com | news@resmed.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.